Avantor (NYSE:AVTR – Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.770-0.830 for the period, compared to the consensus earnings per share estimate of 0.900. The company issued revenue guidance of -.
Analysts Set New Price Targets
Several brokerages recently issued reports on AVTR. Zacks Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Monday, December 29th. Jefferies Financial Group cut Avantor to an “underperform” rating in a report on Wednesday, December 17th. Barclays reiterated an “equal weight” rating and set a $12.00 price objective (down from $15.00) on shares of Avantor in a report on Thursday, October 30th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $12.00 target price (down from $14.00) on shares of Avantor in a report on Thursday, October 30th. Finally, Bank of America downgraded shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price target on the stock. in a research note on Monday, December 15th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Avantor presently has a consensus rating of “Hold” and an average target price of $13.38.
View Our Latest Analysis on AVTR
Avantor Trading Down 14.3%
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.01. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The business had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the business posted $0.27 EPS. The business’s quarterly revenue was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, equities analysts forecast that Avantor will post 1.06 EPS for the current year.
Insider Activity
In related news, Director Sanjeev K. Mehra bought 350,000 shares of the stock in a transaction dated Friday, December 5th. The stock was acquired at an average price of $11.09 per share, for a total transaction of $3,881,500.00. Following the completion of the purchase, the director owned 350,000 shares in the company, valued at $3,881,500. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.20% of the company’s stock.
Avantor News Roundup
Here are the key news stories impacting Avantor this week:
- Positive Sentiment: Quarterly beat on key consensus figures: Q4 revenue of $1.66B and adjusted EPS of $0.22 topped analyst estimates, and adjusted EBITDA and free cash flow remained positive — supportive for near‑term fundamentals. Avantor Reports Fourth Quarter and Full Year 2025 Results
- Positive Sentiment: Management outlined a “revival” program (VWR relaunch, supply‑chain/manufacturing fixes, e‑commerce upgrades) that, if executed, could improve margins and organic growth over time. Avantor Reports Fourth Quarter and Full Year 2025 Results
- Neutral Sentiment: Company released the Q4 earnings slide deck and full earnings-call transcript — useful for investors to assess cadence, guidance color and cost actions. 2025 Q4 – Results – Earnings Call Presentation Q4 2025 Earnings Call Transcript
- Neutral Sentiment: Analyst writeups (Zacks, MSN) provide quick metric comparisons and context on the quarter’s beats vs. year‑ago declines — helpful but not new company guidance. AVTR Q4 Earnings: Key Metrics vs Estimates Avantor reports Q4: Everything you need to know
- Negative Sentiment: Large bearish derivatives flow: unusually heavy put buying (48,044 put contracts) signals traders are positioning for further downside or volatility. (Reported activity on earnings day.)
- Negative Sentiment: Short interest rose sharply in January (~25% increase to ~37.7M shares, ~5.6% of float), intensifying downward pressure and raising the risk of continued pessimism.
- Negative Sentiment: Underlying operational/headline negatives: full‑year GAAP net loss and a one‑year organic sales decline (~3–4%), plus a negative net margin — these factors temper enthusiasm despite the quarter’s beat. Avantor Reports Fourth Quarter and Full Year 2025 Results
Institutional Trading of Avantor
A number of hedge funds have recently made changes to their positions in AVTR. Bank of America Corp DE lifted its position in shares of Avantor by 122.0% during the second quarter. Bank of America Corp DE now owns 7,495,095 shares of the company’s stock worth $100,884,000 after purchasing an additional 4,119,522 shares during the last quarter. Sei Investments Co. raised its stake in Avantor by 3.6% during the third quarter. Sei Investments Co. now owns 4,563,468 shares of the company’s stock valued at $56,952,000 after buying an additional 157,309 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Avantor by 2.2% during the fourth quarter. Bank of New York Mellon Corp now owns 4,417,910 shares of the company’s stock valued at $50,629,000 after buying an additional 93,202 shares in the last quarter. Corient Private Wealth LLC lifted its holdings in Avantor by 10,725.4% during the 2nd quarter. Corient Private Wealth LLC now owns 3,540,650 shares of the company’s stock worth $47,657,000 after buying an additional 3,507,943 shares during the last quarter. Finally, Millennium Management LLC grew its position in shares of Avantor by 20,885.5% in the 3rd quarter. Millennium Management LLC now owns 2,702,510 shares of the company’s stock worth $33,727,000 after acquiring an additional 2,689,632 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Avantor Company Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Stories
- Five stocks we like better than Avantor
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
